Zhenhai Lin
Impact in
-
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 4
- Oncology 7
- CAR-T cell therapy research 1
Zhenhai Lin
15 papers receiving 533 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 150
- Hepatology 53
- Oncology 143
- Molecular Biology 329
- Cell Biology 70
Countries citing papers authored by Zhenhai Lin
This map shows the geographic impact of Zhenhai Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhai Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhai Lin more than expected).
Fields of papers citing papers by Zhenhai Lin
This network shows the impact of papers produced by Zhenhai Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhai Lin. The network helps show where Zhenhai Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhenhai Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 24 | |
| 6 | 2020 | 25 | |
| 7 | 2019 | 13 | |
| 8 | 2018 | 37 | |
| 9 | 2016 | 68 | |
| 10 | 2016 | 178 | |
| 11 | 2016 | 5 | |
| 12 | 2015 | 43 | |
| 13 | 2015 | 6 | |
| 14 | 2014 | 36 | |
| 15 | 2013 | 84 |
About Zhenhai Lin
Zhenhai Lin is a scholar working on Hepatology, Oncology, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 15 papers that have together received 536 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), RNA modifications and cancer (3 papers), Ubiquitin and proteasome pathways (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers), Ferrocene Chemistry and Applications (1 paper), Cancer Mechanisms and Therapy (1 paper), Fibroblast Growth Factor Research (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Cancer Research (150 citations), Hepatology (53 citations), Oncology (143 citations), Molecular Biology (329 citations) and Cell Biology (70 citations). Zhenhai Lin has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Qing‐Hai Ye, Jubo Zhang, Lei Guo, Yi Qin, Xiaoqiang Li, Qi Pan, Wenwei Zhu, Bo Zhang, Yanfeng Liu and Stéphanie Roessler. Their work appears in journals such as Oncotarget, Cancer Cell, Journal of Translational Medicine, Scientific Reports and Cell Biology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.